Nuveen LLC Purchases New Position in AdaptHealth Corp. $AHCO

Key Points

• Nuveen LLC has invested approximately $3.43 million in AdaptHealth Corp., acquiring 316,181 shares, which represents 0.23% of the company's stock as of the end of the most recent quarter.
• Several institutional investors have recently altered their stakes in AdaptHealth, with 82.67% of the stock now owned by hedge funds and institutional investors, indicating significant interest in the company.
• AdaptHealth has received a consensus rating of "Buy" from analysts, with a target price of $13.40, despite recent price adjustments from firms like Royal Bank of Canada and Truist Financial.

Nuveen LLC acquired a new position in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 316,181 shares of the company's stock, valued at approximately $3,427,000. Nuveen LLC owned approximately 0.23% of AdaptHealth at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of AHCO. GAMMA Investing LLC increased its stake in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after purchasing an additional 4,758 shares in the last quarter. Y Intercept Hong Kong Ltd purchased a new stake in shares of AdaptHealth in the 1st quarter worth $114,000. Guggenheim Capital LLC increased its stake in shares of AdaptHealth by 10.1% in the 4th quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock worth $158,000 after purchasing an additional 1,525 shares in the last quarter. Legato Capital Management LLC purchased a new stake in shares of AdaptHealth in the 1st quarter worth $167,000. Finally, Humankind Investments LLC increased its stake in shares of AdaptHealth by 18.3% in the 4th quarter. Humankind Investments LLC now owns 17,979 shares of the company's stock worth $171,000 after purchasing an additional 2,776 shares in the last quarter. 82.67% of the stock is currently owned by hedge funds and other institutional investors.

AdaptHealth Price Performance

Shares of AHCO traded down $0.34 during midday trading on Tuesday, hitting $9.15. 1,068,108 shares of the company traded hands, compared to its average volume of 1,072,403. The firm has a 50 day moving average of $9.33 and a 200-day moving average of $9.25. AdaptHealth Corp. has a 52 week low of $7.11 and a 52 week high of $11.70. The stock has a market cap of $1.24 billion, a price-to-earnings ratio of 16.94, a PEG ratio of 1.06 and a beta of 1.59. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.82 and a current ratio of 1.06.

Insider Activity at AdaptHealth

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the transaction, the director owned 50,045 shares of the company's stock, valued at $486,937.85. This represents a 14.08% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 1.55% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Royal Bank Of Canada dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating for the company in a report on Thursday, May 8th. Truist Financial dropped their target price on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a report on Monday, May 12th. Finally, Wall Street Zen raised shares of AdaptHealth from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Five equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $13.40.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.